Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
2(100.0%)
2Total
N/A(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT04708002Not ApplicableUnknown

Interventional Research With Mixed Methods on an Early Integrated Palliative Approach in Nursing Home

Role: lead

NCT02845817Not ApplicableCompleted

Requests for Euthanasia and Assisted Suicide

Role: collaborator

NCT02778347Unknown

Development and Validation of a Comprehensive Standardised Clinical Assessment Tool for Patient Needs

Role: lead

NCT02742701Unknown

Diabetes and Palliative Care

Role: lead

All 4 trials loaded